Sleep architecture, relaxation, and circadian-signaling research.
8 results
Individual peptide
DSIP is examined in studies of nocturnal signaling and circadian-clock pathways.
Level 3 · Early Human Research
Claim: Sleep architecture and circadian signaling
1 Laboratory2 Animal3 Early Human4 Controlled Human5 Established
Small, older human sleep and pain studies; little modern replication.
View evidence map →Individual peptide
Epithalon is examined in studies of nocturnal signaling and circadian-clock pathways.
Level 3 · Early Human Research
Claim: Sleep architecture and circadian signaling
1 Laboratory2 Animal3 Early Human4 Controlled Human5 Established
Small human studies, largely from a single research group.
View evidence map →Individual peptide
Melatonin is examined in studies of nocturnal signaling and circadian-clock pathways.
Level 5 · Regulatory Review or Established Clinical Use
Claim: Sleep architecture and circadian signaling
1 Laboratory2 Animal3 Early Human4 Controlled Human5 Established
Regulated sleep product with prescription approvals in several regions.
View evidence map →Individual peptide
Researchers are studying N-Acetyl Epitalon Amidate in relation to sleep architecture and circadian signaling.
Level 1 · Laboratory Research
Claim: Sleep architecture and circadian signaling
1 Laboratory2 Animal3 Early Human4 Controlled Human5 Established
Laboratory analog work; no independent human data.
View evidence map →Individual peptide
Research interest in NA Selank amidate centres on relaxation pathways and sleep-wake regulation.
Level 2 · Animal Research
Claim: Sleep architecture and circadian signaling
1 Laboratory2 Animal3 Early Human4 Controlled Human5 Established
Analog of Selank; own data limited to laboratory and animal work.
View evidence map →Individual peptide
Researchers are studying Pinealon in relation to sleep architecture and circadian signaling.
Level 2 · Animal Research
Claim: Sleep architecture and circadian signaling
1 Laboratory2 Animal3 Early Human4 Controlled Human5 Established
Animal and cell bioregulator studies from a limited research group.
View evidence map →Individual peptide
Researchers are studying Selank in relation to sleep architecture and circadian signaling.
Level 4 · Controlled Human Studies
Claim: Sleep architecture and circadian signaling
1 Laboratory2 Animal3 Early Human4 Controlled Human5 Established
Controlled anxiolytic trials in Russia; limited independent replication.
View evidence map →Blend · 2 components
Research interest in this blend centres on relaxation pathways and sleep-wake regulation.
Published evidence — exact blend
Not yet reviewed
Components (reviewed separately)
Every result card shows the same five-segment bar. Each level below matches the color of that segment.
Level 1: Laboratory Research
Observed in cells, tissue, or computational models only.
Level 2: Animal Research
Studied in animal models; results often do not transfer to people.
Level 3: Early Human Research
Human research
Small, early-stage, or uncontrolled studies in humans.
Level 4: Controlled Human Studies
Human research
Randomized or otherwise controlled human trials exist.
Level 5: Regulatory Review or Established Clinical Use
Human research
Reviewed by a regulator or established in clinical practice for a specific use.
Evidence is rated by claim—not popularity. More studies do not always mean stronger evidence.
A higher level describes research maturity. It is not a recommendation or endorsement.
Educational information only. Not medical advice.
0 peptides selected
Select up to 6 peptides to compare.